TSHA 424B5: Secondary offering
Taysha Gene Therapies
Filed with the SEC on · accession 0001193125-26-281288
TSHA filed a 424B5 (prospectus (offering)) with the SEC on Jun 24, 2026. The final terms of an offering of shares or bonds. The stock moved +1.2% by the first close after the filing.
Summary of the filing
Taysha Gene Therapies filed a preliminary prospectus supplement for a public offering of $200,000,000 in common stock and pre-funded warrants, with Jefferies, Goldman Sachs, Piper Sandler, Cantor, and Baird as underwriters.
Key details
How TSHA stock reacted
Close before
$6.86
Jun 23, 2026
First close after
+1.17%
$6.94
5 trading days
-0.73%
$6.81
Since filing
-36.88%
$4.33
✦ Ask GOAX AI about this filing — what it means for TSHA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TSHA?
Click hereFrequently asked questions
What did TSHA file with the SEC on Jun 24, 2026?
TSHA filed a 424B5 (Secondary offering). Taysha Gene Therapies filed a preliminary prospectus supplement for a public offering of $200,000,000 in common stock and pre-funded warrants, with Jefferies, Goldman Sachs, Piper Sandler, Cantor, and Baird as underwriters.
What does a secondary offering mean for TSHA stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did TSHA stock react to this filing?
TSHA closed at $6.86 before the filing and $6.94 on Jun 24, 2026 (+1.17%). Five trading days later: $6.81 (-0.73%).
Other TSHA SEC filings
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 144 · Insider sale plannedJul 10, 2026
- 424B5 · Secondary offeringJun 25, 2026
- 8-K · Secondary offeringJun 25, 2026
- 8-K · Fda approvalJun 22, 2026
- 8-K · SEC filingJun 2, 2026
- 8-K · SEC filingMay 6, 2026
Get alerts when TSHA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days